EF
RVMD icon

Empowered Funds’s Revolution Medicines RVMD Stock Holding History

Empowered Funds’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.75M Buy
52,086
+48,912
+1,541% +$7.14M 0.05% 425
2026
Q1 		$309K Buy
+3,174
New +$321K ﹤0.01% 1814
2025
Q1 		– Sell
-132,679
Closed -$5.8M – 1769
2024
Q4 		$5.8M Buy
+132,679
New +$6.7M 0.08% 338

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Empowered Funds's RVMD Position: Q2 2026 in Review

Empowered Funds increased its Revolution Medicines (RVMD) stake by 1,541% in Q2 2026, buying an estimated $7.14M and bringing the position to 52,086 shares worth $9.75M. The position accounts for 0.05% of the portfolio, ranked #425.

Empowered Funds first reported a position in RVMD in Q4 2024 and has held it in 3 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Empowered Funds held 52,086 shares of Revolution Medicines worth $9.75M as of Q2 2026.
  • Empowered Funds bought 48,912 Revolution Medicines shares in Q2 2026, an estimated $7.14M.
  • Revolution Medicines made up 0.05% of Empowered Funds's portfolio in Q2 2026, its #425 holding.
  • Empowered Funds first reported a position in Revolution Medicines in Q4 2024 and has held it in 3 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.